Asia Green Fund
Deal focus: GPs go big on China biosynthesis
Advances in synthetic biology and China’s carbon-neutral ambitions have prompted investors to re-examine bio-manufacturing plays. Mojia Biotech is among the beneficiaries
China bio-manufacturing start-up Mojia raises $80m
Temasek Holdings has led a USD 80m Series B round for Shanghai-based bio-manufacturing start-up Mojia Biotech.
Deal focus: Asia Green Fund secures DuPont carve-out
Asia Green Fund reunited with the team at special situations investor BroadPeak Global for the $510 million acquisition of DuPont's clean energy unit. Driving expansion in China is now the priority